MetLife Investment Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
59,249
+26,291
+80% +$127K ﹤0.01% 2359
2026
Q1
$175K Buy
32,958
+4,029
+14% +$24.8K ﹤0.01% 2297
2025
Q4
$223K Buy
28,929
+2,784
+11% +$24.8K ﹤0.01% 2218
2025
Q3
$231K Hold
26,145
﹤0.01% 2238
2025
Q2
$109K Buy
26,145
+4,120
+19% +$25.8K ﹤0.01% 2506
2025
Q1
$133K Sell
22,025
-3,631
-14% -$22.2K ﹤0.01% 2396
2024
Q4
$133K Buy
+25,656
New +$101K ﹤0.01% 2498
2022
Q2
Sell
-4,045
Closed -$68.4K 2910
2022
Q1
$68.4K Sell
4,045
-1,389
-26% -$23.9K ﹤0.01% 2657
2021
Q4
$134K Buy
5,434
+2,494
+85% +$78.7K ﹤0.01% 2291
2021
Q3
$109K Sell
2,940
-2,534
-46% -$93.1K ﹤0.01% 2412
2021
Q2
$267K Buy
5,474
+3,465
+172% +$144K ﹤0.01% 1968
2021
Q1
$59.6K Sell
2,009
-4,524
-69% -$127K ﹤0.01% 2277
2020
Q4
$167K Buy
6,533
+5,200
+390% +$104K ﹤0.01% 2079
2020
Q3
$19.4K Sell
1,333
-5,401
-80% -$89.4K ﹤0.01% 2284
2020
Q2
$139K Buy
+6,734
New +$178K ﹤0.01% 2089
2019
Q1
Sell
-2,224
Closed -$89.7K 2597
2018
Q4
$89.7K Hold
2,224
﹤0.01% 2318
2018
Q3
$194K Hold
2,224
﹤0.01% 2099
2018
Q2
$184K Buy
+2,224
New +$136K ﹤0.01% 1958

Other funds holding VSTM

MetLife Investment Management's VSTM Position: Q2 2026 in Review

MetLife Investment Management increased its Verastem (VSTM) stake by 80% in Q2 2026, buying an estimated $127K and bringing the position to 59,249 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

MetLife Investment Management first reported a position in VSTM in Q2 2018 and has held it in 18 quarters since. The position peaked at $267K in Q2 2021. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • MetLife Investment Management held 59,249 shares of Verastem worth $226K as of Q2 2026.
  • MetLife Investment Management bought 26,291 Verastem shares in Q2 2026, an estimated $127K.
  • Verastem made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2359 holding.
  • MetLife Investment Management first reported a position in Verastem in Q2 2018 and has held it in 18 quarters since.
  • MetLife Investment Management's Verastem position peaked at $267K in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.